Hirsch J D, Gagnon J P, Camp R
School of Pharmacy, University of North Carolina, Chapel Hill 27599-7360.
Am Pharm. 1990 Mar;NS30(3):20-5.
A study of patients, physicians, and third party prescription plan administrators was conducted to identify those pharmacy services they believe are important and valuable and to determine whether third party plan administrators would reimburse pharmacists for such services. Patient and physician focus groups indicated that both wanted personalized services related to medications. Physicians believe that pharmacists are talking to patients about their medications, whereas patients want more drug information but report that pharmacists are not always providing such information. A mail survey of 41 third party prescription plan administrators indicated they believe that pharmacy services are important to consumers and that pharmacists are already providing most of the services identified. One-third of the third party administrators said their companies would consider implementing a structured pharmacist incentive plan to improve enrollee satisfaction. Those whose companies would not most often gave "increased cost" as the reason. No clear relationship was shown between number or type of services and the incentive value offered. Providing administrators with evidence that enhanced pharmacy services will increase overall program cost savings may lead to implementation of pharmacy incentives.
针对患者、医生和第三方处方计划管理人员开展了一项研究，以确定他们认为重要且有价值的那些药学服务，并判断第三方计划管理人员是否会为这些服务向药剂师支付费用。患者和医生焦点小组表明，双方都希望获得与药物相关的个性化服务。医生认为药剂师会与患者谈论其用药情况，而患者想要更多药物信息，但表示药剂师并非总是提供此类信息。对41名第三方处方计划管理人员进行的邮件调查表明，他们认为药学服务对消费者很重要，并且药剂师已经在提供所确定的大部分服务。三分之一的第三方管理人员表示，他们公司会考虑实施结构化的药剂师激励计划以提高参保者满意度。那些公司不会这样做的管理人员最常给出的理由是“成本增加”。服务的数量或类型与所提供的激励价值之间未显示出明确的关系。向管理人员提供证据表明强化的药学服务将增加总体项目成本节省，可能会促使实施药学激励措施。
